Jones Jeffrey Alan — SEC Form 4 filings
SEC reporting owner CIK 1914647. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-25.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-23 to 2026-02-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 23,723 shares, $273,553 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 4,982 shares @ $13.62 ($67,855) in Cullinan Therapeutics, Inc., filed 2026-02-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | Chief Medical Officer | 8 | — | 5 legs · 23,723 sh · $273,553 | 5 |
Form 4 filings — Jones Jeffrey Alan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-25 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,582 @ $14.47 | EDGAR |
| 2026-02-23 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,982 @ $13.62 | EDGAR |
| 2026-02-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,632 @ $9.67 | EDGAR |
| 2025-02-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,895 @ $8.53 | EDGAR |
| 2025-02-21 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,632 @ $11.41 | EDGAR |
| 2024-02-23 | 4 | Cullinan Oncology, Inc. (CGEM) | Grant/award (A): 62,500 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1914647 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →